Decision Resources Group finds that, according to surveyed U.S. and EU5 dermatologists, short-term and long-term effects on psoriatic plaque clearance are two of the attributes that most strongly influence their...
Decision Resources Group finds that, according to surveyed U.S. and EU5 dermatologists, short-term and long-term effects on psoriatic plaque clearance are two of the attributes that most strongly influence their...
Alimera Sciences, Inc. (NASDAQ: ALIM) ("Alimera"), a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that it will...
Alimera Sciences, Inc. (NASDAQ: ALIM) ("Alimera"), a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that it will...
OTTAWA, July 24, 2014 The Canadian Society of Allergy and Clinical Immunology (CSACI) would like to comment on the death of Mrs. Lucie Roussel, Mayor of La Prairie, on Sunday. As previously reported, Mrs. Roussel stepped...
OTTAWA, July 24, 2014 The Canadian Society of Allergy and Clinical Immunology (CSACI) would like to comment on the death of Mrs. Lucie Roussel, Mayor of La Prairie, on Sunday. As previously reported, Mrs. Roussel stepped...
LSI Medience Corporation today announced that the company has signed an Agreement with Kineticos, a Raleigh-Durham, NC based life sciences consulting company. Kineticos will support LSI Medience in identifying...
LSI Medience Corporation today announced that the company has signed an Agreement with Kineticos, a Raleigh-Durham, NC based life sciences consulting company. Kineticos will support LSI Medience in identifying...
GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that the U.S. Food and Drug Administration (FDA) has approved Flonase® Allergy Relief (fluticasone propionate 50 mcg spray), containing the No. 1 prescribed allergy...
GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that the U.S. Food and Drug Administration (FDA) has approved Flonase® Allergy Relief (fluticasone propionate 50 mcg spray), containing the No. 1 prescribed allergy...
The Parkinson's Disease Foundation® (PDF®) is pleased to announce $1.3 million in funding for more than 30 investigator-initiated research projects to help solve, treat and end Parkinson's disease. Chosen through...
The Parkinson's Disease Foundation® (PDF®) is pleased to announce $1.3 million in funding for more than 30 investigator-initiated research projects to help solve, treat and end Parkinson's disease. Chosen through...
Cannabis and Legal Medical Marijuana companies adapt to latest industry developments with innovative operations and products to meet evolving expectations of both consumers and government regulations: OSL Holdings (OTC:...
Cannabis and Legal Medical Marijuana companies adapt to latest industry developments with innovative operations and products to meet evolving expectations of both consumers and government regulations: OSL Holdings (OTC:...
Research and Markets has announced the addition of the "Global Cell Culture Market 2014-2018" report to their offering.
Research and Markets has announced the addition of the "Global Cell Culture Market 2014-2018" report to their offering.
Research and Markets has announced the addition of the "Global Genomics and Proteomics Analytical Instruments Market 2014-2018" report to their offering.
Research and Markets has announced the addition of the "Global Genomics and Proteomics Analytical Instruments Market 2014-2018" report to their offering.
OSL Holdings (OTCQB: OSLH) ("OSL" or "the Company"), a socially conscious business model dedicated to consumer advocacy, social activism and the advancement of civil liberties through the power of commerce, today released...
OSL Holdings (OTCQB: OSLH) ("OSL" or "the Company"), a socially conscious business model dedicated to consumer advocacy, social activism and the advancement of civil liberties through the power of commerce, today released...
Perrigo Company (NYSE: PRGO; TASE) today announced that it has received an AB therapeutic equivalent rating from the U.S. Food and Drug Administration (FDA) for its previously approved New Drug Application (NDA) for...
Perrigo Company (NYSE: PRGO; TASE) today announced that it has received an AB therapeutic equivalent rating from the U.S. Food and Drug Administration (FDA) for its previously approved New Drug Application (NDA) for...
GliaCure, Inc., a company focused on developing novel, non-neuronal therapies for a range of neurological and neuropsychiatric disorders, announced today that it has appointed Joseph S. Zakrzewski to the Company's...
GliaCure, Inc., a company focused on developing novel, non-neuronal therapies for a range of neurological and neuropsychiatric disorders, announced today that it has appointed Joseph S. Zakrzewski to the Company's...
A consortium of 12 New Jersey hospitals achieved $113 million in healthcare savings under a pilot project that encourages hospitals and physicians to work together to provide more efficient, high-quality care, according to...
A consortium of 12 New Jersey hospitals achieved $113 million in healthcare savings under a pilot project that encourages hospitals and physicians to work together to provide more efficient, high-quality care, according to...
CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiorenal and infectious disease, today announces receipt of...
CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiorenal and infectious disease, today announces receipt of...
Kinex Pharmaceuticals announced the receipt of an allowance by the US FDA for the Company's KX2-391 Ointment for the commencement of a Phase I clinical study in actinic keratosis. This is the Company's third IND to...
Kinex Pharmaceuticals announced the receipt of an allowance by the US FDA for the Company's KX2-391 Ointment for the commencement of a Phase I clinical study in actinic keratosis. This is the Company's third IND to...
Talyst, a market leader in pharmacy automation, will be exhibiting at the 2014 National Association of State Veterans Homes (NASVH) Summer Conference in Charleston, South Carolina. The goal of the NASVH is to ensure that...
Talyst, a market leader in pharmacy automation, will be exhibiting at the 2014 National Association of State Veterans Homes (NASVH) Summer Conference in Charleston, South Carolina. The goal of the NASVH is to ensure that...
SRI International has been awarded a new $49 million, seven-year contract with the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, to conduct preclinical...
SRI International has been awarded a new $49 million, seven-year contract with the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, to conduct preclinical...
The American Association for Homecare (AAHomecare) yesterday announced that Brightree is supporting its mission to help address audit issues in the HME industry through a new and exclusive agreement to be the information...
The American Association for Homecare (AAHomecare) yesterday announced that Brightree is supporting its mission to help address audit issues in the HME industry through a new and exclusive agreement to be the information...
A new study published in the June issue of the Minerva Medica found that supplementation with Pycnogenol® (pic-noj-en-all), a natural antioxidant plant extract from French maritime pine tree bark, significantly improves...
A new study published in the June issue of the Minerva Medica found that supplementation with Pycnogenol® (pic-noj-en-all), a natural antioxidant plant extract from French maritime pine tree bark, significantly improves...
Decision Resources Group finds that, for the treatment of asthma, pulmonologists in the EU5 countries (France, Germany, Italy, Spain and the United Kingdom) hold a generally positive view of the first once-daily...
Decision Resources Group finds that, for the treatment of asthma, pulmonologists in the EU5 countries (France, Germany, Italy, Spain and the United Kingdom) hold a generally positive view of the first once-daily...
A parent's bariatric surgery could be an opportunity to break the cycle of obesity in an overweight son – body mass index (BMI) of 85 to 94 – according to a Geisinger research study published in the July issue of...
A parent's bariatric surgery could be an opportunity to break the cycle of obesity in an overweight son – body mass index (BMI) of 85 to 94 – according to a Geisinger research study published in the July issue of...
The Centers for Medicare & Medicaid Services (CMS) has awarded a Quality Innovation Network - Quality Improvement Organization (QIN-QIO) contract to support its work improving health care for Medicare beneficiaries in...
The Centers for Medicare & Medicaid Services (CMS) has awarded a Quality Innovation Network - Quality Improvement Organization (QIN-QIO) contract to support its work improving health care for Medicare beneficiaries in...
Advanced Biologics, currently attending the NASS Summer Spine Meeting in Amelia Island, FL, announced today the publishing of two abstracts within The Bone and Joint Journal. Initially presented at the European...
Advanced Biologics, currently attending the NASS Summer Spine Meeting in Amelia Island, FL, announced today the publishing of two abstracts within The Bone and Joint Journal. Initially presented at the European...
Consolidated Net Profit increased by 43.65 % to Rs. 1848.46 Mn Business Highlights India Business grew by 20.87% to Rs. 3,971.59 MnUS Business grew by 9.33% to Rs. 4,886.70 MnRest of World (ROW) Business grew by 20.67%...
Consolidated Net Profit increased by 43.65 % to Rs. 1848.46 Mn Business Highlights India Business grew by 20.87% to Rs. 3,971.59 MnUS Business grew by 9.33% to Rs. 4,886.70 MnRest of World (ROW) Business grew by 20.67%...
This year, Passport Health, the largest and leading provider of travel medicine and immunization services in North America, celebrates its 20 year anniversary. The company was founded in 1994 by Fran Lessans, a Registered...
This year, Passport Health, the largest and leading provider of travel medicine and immunization services in North America, celebrates its 20 year anniversary. The company was founded in 1994 by Fran Lessans, a Registered...
Research and Markets has announced the addition of the "Machine Health Monitoring Market by Product, Component, Application and Geography - Global Forecast to 2014 - 2020" report to their offering.
Research and Markets has announced the addition of the "Machine Health Monitoring Market by Product, Component, Application and Geography - Global Forecast to 2014 - 2020" report to their offering.
Lazarus Effect, a medical device company focused on the development of novel interventional devices to facilitate removal of blood clots, announced today that the United States Patent and Trademark Office has issued a new...
Lazarus Effect, a medical device company focused on the development of novel interventional devices to facilitate removal of blood clots, announced today that the United States Patent and Trademark Office has issued a new...
Emergency Medical Products (EMP), a leading distributor of emergency medical equipment and supplies, announced the addition of CPR RsQ Assist® to its growing line of medical supplies and equipment.
Emergency Medical Products (EMP), a leading distributor of emergency medical equipment and supplies, announced the addition of CPR RsQ Assist® to its growing line of medical supplies and equipment.
Sir Bob Geldof Says the 'Last Mile' of the HIV Epidemic Must be Funded Sir Bob Geldof told delegates at AIDS 2014, the 20th International AIDS Conference, that the "preposterous reluctance" of governments to fund...
Sir Bob Geldof Says the 'Last Mile' of the HIV Epidemic Must be Funded Sir Bob Geldof told delegates at AIDS 2014, the 20th International AIDS Conference, that the "preposterous reluctance" of governments to fund...
The nation's emergency physicians handle tragic situations too often, but few things are more upsetting than the sudden death of a child - killed by a piece of a furniture, appliance or a television falling on them.
The nation's emergency physicians handle tragic situations too often, but few things are more upsetting than the sudden death of a child - killed by a piece of a furniture, appliance or a television falling on them.
The National Necrotizing Fasciitis Foundation (NNFF) today is calling attention to an interview on RadioMD with Dr. John Crew, Medical Director of the Advanced Wound Care Center at Seton Medical Center in Daly City,...
The National Necrotizing Fasciitis Foundation (NNFF) today is calling attention to an interview on RadioMD with Dr. John Crew, Medical Director of the Advanced Wound Care Center at Seton Medical Center in Daly City,...
SINGAPORE, July 24, 2014 /PRNewswire/ - Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I.F), a developer of leading-edge photonics technologies for medical, industrial and scientific markets, today announced that its...
SINGAPORE, July 24, 2014 /PRNewswire/ - Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I.F), a developer of leading-edge photonics technologies for medical, industrial and scientific markets, today announced that its...
What: AFFiRiS AG, Vienna, Austria will present data from a Phase I clinical trial of PD01A, a vaccine approach that aims to slow or stop Parkinson's disease progression. The Michael J. Fox Foundation supported the...
What: AFFiRiS AG, Vienna, Austria will present data from a Phase I clinical trial of PD01A, a vaccine approach that aims to slow or stop Parkinson's disease progression. The Michael J. Fox Foundation supported the...
The University of Maryland (UMD) Fischell Department of Bioengineering and UMD's Center of Excellence in Regulatory Science and Innovation (CERSI) will launch a new Graduate Certificate in Regulatory Science and...
The University of Maryland (UMD) Fischell Department of Bioengineering and UMD's Center of Excellence in Regulatory Science and Innovation (CERSI) will launch a new Graduate Certificate in Regulatory Science and...
Boston Children's Hospital's Global Pediatric Summit + Awards, Taking on Tomorrow (#PedInno14), will feature an "Innovation Tank" – a forum designed to give pediatric health care innovators an opportunity to pitch...
Boston Children's Hospital's Global Pediatric Summit + Awards, Taking on Tomorrow (#PedInno14), will feature an "Innovation Tank" – a forum designed to give pediatric health care innovators an opportunity to pitch...
Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) today reported financial results for the second quarter ended June 30, 2014.
Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) today reported financial results for the second quarter ended June 30, 2014.
e-MDs, a leading provider of electronic health records (EHRs) and practice management (PM) solutions, is ranked fifth overall in the Medscape EHR Report 2014 and in the top five in 13 other categories, the company...
e-MDs, a leading provider of electronic health records (EHRs) and practice management (PM) solutions, is ranked fifth overall in the Medscape EHR Report 2014 and in the top five in 13 other categories, the company...
Neogen Corporation (Nasdaq: NEOG) advised market analysts today that future forecasts of its potential revenue from new rodenticide research are premature. In its regular quarterly conference call to investors and analysts...
Neogen Corporation (Nasdaq: NEOG) advised market analysts today that future forecasts of its potential revenue from new rodenticide research are premature. In its regular quarterly conference call to investors and analysts...
Imprimis Pharmaceuticals, Inc. (Nasdaq: IMMY), a vertically-integrated specialty pharmaceutical company focused on the development and commercialization of proprietary sterile and topical compounded drug formulations,...
Imprimis Pharmaceuticals, Inc. (Nasdaq: IMMY), a vertically-integrated specialty pharmaceutical company focused on the development and commercialization of proprietary sterile and topical compounded drug formulations,...
The Mesothelioma Compensation Center knows that many diagnosed victims of mesothelioma, or their family members discount the compensation possibilities because of the age of the victim, and as they would like to explain...
The Mesothelioma Compensation Center knows that many diagnosed victims of mesothelioma, or their family members discount the compensation possibilities because of the age of the victim, and as they would like to explain...
In any given hospital in the country at any given time, one in 25 patients has at least one hospital-acquired infection, according to the Centers of Disease Control and Prevention. What's more, many of these infections...
In any given hospital in the country at any given time, one in 25 patients has at least one hospital-acquired infection, according to the Centers of Disease Control and Prevention. What's more, many of these infections...
As part of its ongoing effort to help women pharmacists become business owners, Cardinal Health will host its annual Pharmacy Ownership Boot Camp on July 26 as part of the company's Retail Business Conference in...
As part of its ongoing effort to help women pharmacists become business owners, Cardinal Health will host its annual Pharmacy Ownership Boot Camp on July 26 as part of the company's Retail Business Conference in...
The Female Health Company (NASDAQ-CM: FHCO), today announced that it will host an investor conference call to discuss its operating results for the third quarter and the first nine months of FY2014 on Thursday, July 31,...
The Female Health Company (NASDAQ-CM: FHCO), today announced that it will host an investor conference call to discuss its operating results for the third quarter and the first nine months of FY2014 on Thursday, July 31,...
Goldman Small Cap Research, a stock market research firm focused on the small cap and micro cap sectors, announced today that it has released a new research report on BioCorRx, Inc. (OTCQB – BICX). The healthcare solutions...
Goldman Small Cap Research, a stock market research firm focused on the small cap and micro cap sectors, announced today that it has released a new research report on BioCorRx, Inc. (OTCQB – BICX). The healthcare solutions...
Blueprint Medicines (Blueprint), a leader in discovering highly selective kinase inhibitors for genomically defined cancer patients, today announced the appointment of Jeffrey Albers as chief executive officer (CEO). Mr....
Blueprint Medicines (Blueprint), a leader in discovering highly selective kinase inhibitors for genomically defined cancer patients, today announced the appointment of Jeffrey Albers as chief executive officer (CEO). Mr....
Second Quarter and Recent Highlights: Appointed Pat Mackin as President and Chief Executive Officer effective September 2, 2014 Product revenues grew 12 percent year-over-year to $20.4 million BioGlue® revenues grew 14...
Second Quarter and Recent Highlights: Appointed Pat Mackin as President and Chief Executive Officer effective September 2, 2014 Product revenues grew 12 percent year-over-year to $20.4 million BioGlue® revenues grew 14...
WIRB-Copernicus Group® ("WCG")™, the world's largest provider of regulatory and ethical review services for clinical research, announced today that it has acquired Alliance Biosciences. Formerly a division of Richmond,...
WIRB-Copernicus Group® ("WCG")™, the world's largest provider of regulatory and ethical review services for clinical research, announced today that it has acquired Alliance Biosciences. Formerly a division of Richmond,...
Bruin Biometrics (BBI), a pioneer in biometric-sensor based medical devices, announced today that after two weeks of clinical briefings to over 200 pressure ulcer experts throughout the European Union, it gained...
Bruin Biometrics (BBI), a pioneer in biometric-sensor based medical devices, announced today that after two weeks of clinical briefings to over 200 pressure ulcer experts throughout the European Union, it gained...
Cancer patients in the west of Scotland will gain access to state-of-the-art cancer treatment closer to home when a new radiotherapy center opens near Glasgow next year. Varian Medical Systems (NYSE: VAR) has been selected...
Cancer patients in the west of Scotland will gain access to state-of-the-art cancer treatment closer to home when a new radiotherapy center opens near Glasgow next year. Varian Medical Systems (NYSE: VAR) has been selected...
Celsion Corporation (NASDAQ: CLSN) announced today positive interim data from its ongoing open-label Phase 2 DIGNITY Trial of ThermoDox® in Recurrent Chest Wall Breast Cancer (RCWBC). The trial is designed to enroll 20...
Celsion Corporation (NASDAQ: CLSN) announced today positive interim data from its ongoing open-label Phase 2 DIGNITY Trial of ThermoDox® in Recurrent Chest Wall Breast Cancer (RCWBC). The trial is designed to enroll 20...
Royal Philips (NYSE: PHG AEX: PHIA) today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration to market its innovative ultra mobile ultrasound system, VISIQ, in the U.S. VISIQ is the...
Royal Philips (NYSE: PHG AEX: PHIA) today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration to market its innovative ultra mobile ultrasound system, VISIQ, in the U.S. VISIQ is the...
Lpath, Inc. (NASDAQ: LPTN), the industry leader in bioactive lipid-targeted therapeutics, reported interim results in a Phase 2a single-arm, open-label trial where ASONEP™ is being investigated as a treatment for...
Lpath, Inc. (NASDAQ: LPTN), the industry leader in bioactive lipid-targeted therapeutics, reported interim results in a Phase 2a single-arm, open-label trial where ASONEP™ is being investigated as a treatment for...
Valeant Pharmaceuticals International, Inc. ("Valeant") (NYSE:VRX) (TSX:VRX) announced today that it has filed a detailed complaint with the Autorite des marches financiers ("AMF") regarding Allergan, Inc.'s (NYSE:...
Valeant Pharmaceuticals International, Inc. ("Valeant") (NYSE:VRX) (TSX:VRX) announced today that it has filed a detailed complaint with the Autorite des marches financiers ("AMF") regarding Allergan, Inc.'s (NYSE:...
Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases, and cancer, announced that it will...
Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases, and cancer, announced that it will...
Bayer HealthCare today announced positive results from a Phase III trial that evaluated a 15% foam formulation of its compound azelaic acid (AzA) for the topical treatment of inflammatory papules and pustules of rosacea....
Bayer HealthCare today announced positive results from a Phase III trial that evaluated a 15% foam formulation of its compound azelaic acid (AzA) for the topical treatment of inflammatory papules and pustules of rosacea....
To help health care organizations better understand trends in the cardiovascular market that could impact patient care and the bottom line, Novation released its Spring 2014 CV Watch, "Innovations in Cardiovascular Devices."
To help health care organizations better understand trends in the cardiovascular market that could impact patient care and the bottom line, Novation released its Spring 2014 CV Watch, "Innovations in Cardiovascular Devices."
Nutrition needs are greater when breastfeeding than any other time in a woman's life, including pregnancy, yet new research reveals diet alone may not be enough to meet the high nutritional needs during this important...
Nutrition needs are greater when breastfeeding than any other time in a woman's life, including pregnancy, yet new research reveals diet alone may not be enough to meet the high nutritional needs during this important...
Misonix, Inc. (NASDAQ: MSON), an international surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products for spine surgery, skull based surgery, neurosurgery, wound...
Misonix, Inc. (NASDAQ: MSON), an international surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products for spine surgery, skull based surgery, neurosurgery, wound...
Zimmer Holdings, Inc. (NYSE and SIX: ZMH) today reported financial results for the quarter ended June 30, 2014. The Company reported second quarter net sales of $1.18 billion, an increase of 1.2% reported and 0.9%...
Zimmer Holdings, Inc. (NYSE and SIX: ZMH) today reported financial results for the quarter ended June 30, 2014. The Company reported second quarter net sales of $1.18 billion, an increase of 1.2% reported and 0.9%...
MedVantx, Inc., the company that has built an innovative new direct-to-consumer prescription delivery channel in physician offices, MedStart Connect, today announced it eliminates many of the underlying issues related to...
MedVantx, Inc., the company that has built an innovative new direct-to-consumer prescription delivery channel in physician offices, MedStart Connect, today announced it eliminates many of the underlying issues related to...
HIGHLIGHTS: Q2 2014 Results (all percentage changes are against the same period in 2013) Reported sales increased 3% to $701 million. Sales grew organically by 2%, and changes in foreign currency exchange rates added one...
HIGHLIGHTS: Q2 2014 Results (all percentage changes are against the same period in 2013) Reported sales increased 3% to $701 million. Sales grew organically by 2%, and changes in foreign currency exchange rates added one...
Market Diagnostics International LLC ("MDxI") today announced the availability of IVD Insights™ LabFile, a data resource that sets a new standard for defining the US clinical laboratory universe and identifying target In...
Market Diagnostics International LLC ("MDxI") today announced the availability of IVD Insights™ LabFile, a data resource that sets a new standard for defining the US clinical laboratory universe and identifying target In...
WHEATON® today highlighted products to be featured at the 2014 AACC Annual Meeting that provide unique solutions addressing the specific needs of clinical laboratory and other clinical life sciences customers. These...
WHEATON® today highlighted products to be featured at the 2014 AACC Annual Meeting that provide unique solutions addressing the specific needs of clinical laboratory and other clinical life sciences customers. These...
Boston Scientific Corporation (NYSE: BSX) generated sales of $1.873 billion during the second quarter ended June 30, 2014, compared to the company's guidance range for the quarter of $1.840 to $1.890 billion. This...
Boston Scientific Corporation (NYSE: BSX) generated sales of $1.873 billion during the second quarter ended June 30, 2014, compared to the company's guidance range for the quarter of $1.840 to $1.890 billion. This...
West Pharmaceutical Services, Inc. (NYSE:WST) announced today that it will release second quarter 2014 financial results before the market opens on Thursday, July 31, 2014 and will follow with a conference call to discuss...
West Pharmaceutical Services, Inc. (NYSE:WST) announced today that it will release second quarter 2014 financial results before the market opens on Thursday, July 31, 2014 and will follow with a conference call to discuss...
OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) announced today that the Company's second quarter 2014 financial results will be released on Thursday, August 7, 2014, and that the Company will host a conference call and...
OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) announced today that the Company's second quarter 2014 financial results will be released on Thursday, August 7, 2014, and that the Company will host a conference call and...
Second-quarter 2014 revenue declined 17 percent driven by the impact of U.S. patent expirations for Cymbalta and Evista, partially offset by volume growth in several other products. Expense management initiatives resulted...
Second-quarter 2014 revenue declined 17 percent driven by the impact of U.S. patent expirations for Cymbalta and Evista, partially offset by volume growth in several other products. Expense management initiatives resulted...
Spherix Incorporated (NASDAQ:SPEX) -- an intellectual property development company committed to the fostering and monetization of intellectual property, today announced that the Company will issue a business update for the...
Spherix Incorporated (SPEX) -- an intellectual property development company committed to the fostering and monetization of intellectual property, today announced that the Company will issue a business update for the period...
Cognizant (NASDAQ: CTSH) today announced that it has been selected by TransCelerate BioPharma Inc., a non-profit organization with membership representation from 19 major pharmaceutical companies, to develop a...
Cognizant (NASDAQ: CTSH) today announced that it has been selected by TransCelerate BioPharma Inc., a non-profit organization with membership representation from 19 major pharmaceutical companies, to develop a...
ndd Medical Technologies, a leader in innovative mobile pulmonary function testing (PFT) employing precise ultrasound technology, announced that its EasyOne Pro® has been chosen as the instrument to measure Carbon Monoxide...
ndd Medical Technologies, a leader in innovative mobile pulmonary function testing (PFT) employing precise ultrasound technology, announced that its EasyOne Pro® has been chosen as the instrument to measure Carbon Monoxide...
Cypher Genomics, Inc., the genome informatics company, announced today a co-promotion agreement with Illumina to facilitate the development of genomic-based biomarkers from whole genome sequence data for precision medicine...
Cypher Genomics, Inc., the genome informatics company, announced today a co-promotion agreement with Illumina to facilitate the development of genomic-based biomarkers from whole genome sequence data for precision medicine...
MT Services LLC, The Lawsuit Settlement News Reporting company, which operates a lawsuit help center: lawsuitsettlementnews.com, reports today Johnson & Johnson's $2.5 billion lawsuit settlement was for an...
MT Services LLC, The Lawsuit Settlement News Reporting company, which operates a lawsuit help center: lawsuitsettlementnews.com, reports today Johnson & Johnson's $2.5 billion lawsuit settlement was for an...
Lyfebulb, the International Pemphigus Pemphigoid Foundation (IPPF) and Immune Pharmaceuticals Inc. (OTCQX and NASDAQ OMX First North Premier, Stockholm: "IMNP."; "Immune" or "the Company"), announced a collaboration to...
Lyfebulb, the International Pemphigus Pemphigoid Foundation (IPPF) and Immune Pharmaceuticals Inc. (OTCQX and NASDAQ OMX First North Premier, Stockholm: "IMNP."; "Immune" or "the Company"), announced a collaboration to...
Announced at the 20th International AIDS Conference in Melbourne, the agreement seeks to increase access to a promising new HIV medicine in 112 developing countries At the AIDS 2014 conference in Melbourne today, the...
Announced at the 20th International AIDS Conference in Melbourne, the agreement seeks to increase access to a promising new HIV medicine in 112 developing countries At the AIDS 2014 conference in Melbourne today, the...
Pfenex Inc. (NYSE MKT: PFNX) today announced the pricing of its initial public offering of 8,333,333 shares of its common stock at a price to the public of $6.00 per share. In addition, Pfenex has granted the underwriters...
Pfenex Inc. (NYSE MKT: PFNX) today announced the pricing of its initial public offering of 8,333,333 shares of its common stock at a price to the public of $6.00 per share. In addition, Pfenex has granted the underwriters...
Sysmex America, Inc., the United States subsidiary for Sysmex Corporation, Kobe, Japan, announced that the company's President and Chief Executive Officer, John Kershaw, has been appointed an Executive Officer of...
Sysmex America, Inc., the United States subsidiary for Sysmex Corporation, Kobe, Japan, announced that the company's President and Chief Executive Officer, John Kershaw, has been appointed an Executive Officer of...
As a growing number of individuals and families seek new opportunities in the U.S., they'll face a number of hurdles along the way. That's why they can take heart in knowing they'll find a caring and highly...
As a growing number of individuals and families seek new opportunities in the U.S., they'll face a number of hurdles along the way. That's why they can take heart in knowing they'll find a caring and highly...
Continuing to advance the development of innovative treatment options for coronary artery disease, Boston Scientific Corporation (NYSE: BSX) has received CE Mark and begun the European market launch of the Agent™...
Continuing to advance the development of innovative treatment options for coronary artery disease, Boston Scientific Corporation (NYSE: BSX) has received CE Mark and begun the European market launch of the Agent™...
Streamline Health Solutions, Inc. (NASDAQ: STRM), a leading provider of transformational data-driven solutions to help healthcare providers reduce exposure to risk, enhance clinical, financial, and operational performance,...
Streamline Health Solutions, Inc. (NASDAQ: STRM), a leading provider of transformational data-driven solutions to help healthcare providers reduce exposure to risk, enhance clinical, financial, and operational performance,...
UBM Medica US today announced the launch of NeurologyTimes.com – a new online community and information resource for neurologists and other healthcare providers to help them better manage and treat their patients with...
UBM Medica US today announced the launch of NeurologyTimes.com – a new online community and information resource for neurologists and other healthcare providers to help them better manage and treat their patients with...
El Camino Hospital has been ranked as one of the best hospitals for 2014-15 in the San Jose, California metropolitan area by U.S. News & World Report. The annual U.S. News Best Hospitals rankings, now in their 25th...
El Camino Hospital has been ranked as one of the best hospitals for 2014-15 in the San Jose, California metropolitan area by U.S. News & World Report. The annual U.S. News Best Hospitals rankings, now in their 25th...
Quest Diagnostics (NYSE:DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors has elected Vicky Gregg to serve as a director, effective immediately,...
Quest Diagnostics (NYSE:DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors has elected Vicky Gregg to serve as a director, effective immediately,...
Skilled Healthcare Group, Inc. (NYSE: SKH) announced today that it expects to release its results for the quarter ended June 30, 2014 after the market closes on Monday, August 11, 2014. A conference call and webcast will...
Skilled Healthcare Group, Inc. (NYSE: SKH) announced today that it expects to release its results for the quarter ended June 30, 2014 after the market closes on Monday, August 11, 2014. A conference call and webcast will...
Varian Medical Systems (NYSE:VAR) today is reporting net earnings of $1.02 per diluted share in the third quarter of fiscal year 2014. Net earnings were negatively impacted by about $0.06 per diluted share due to an...
Varian Medical Systems (NYSE:VAR) today is reporting net earnings of $1.02 per diluted share in the third quarter of fiscal year 2014. Net earnings were negatively impacted by about $0.06 per diluted share due to an...
InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in embolic protection systems ("EPS"), today announced its financial and operating results for the second quarter, which ended June 30, 2014.
InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in embolic protection systems ("EPS"), today announced its financial and operating results for the second quarter, which ended June 30, 2014.
Sangamo BioSciences, Inc. (NASDAQ: SGMO) today reported its second quarter 2014 financial results and accomplishments.
Sangamo BioSciences, Inc. (NASDAQ: SGMO) today reported its second quarter 2014 financial results and accomplishments.
Corporate Directors Forum is recognizing six San Diego directors for their high standards in corporate governance at its annual Director of the Year awards.
Corporate Directors Forum is recognizing six San Diego directors for their high standards in corporate governance at its annual Director of the Year awards.
Thursday, July 24 may just be another day on the calendar, but for the dentist and team at the new Aspen Dental practice in Vienna, West Virginia, it marks a historic moment.
Thursday, July 24 may just be another day on the calendar, but for the dentist and team at the new Aspen Dental practice in Vienna, West Virginia, it marks a historic moment.
Twenty of the Pulmonary Fibrosis Foundation's advocates have come together to inaugurate PFF Ambassador program, a group of idiopathic pulmonary fibrosis (IPF) patients and caregivers who are committed to share...
Twenty of the Pulmonary Fibrosis Foundation's advocates have come together to inaugurate PFF Ambassador program, a group of idiopathic pulmonary fibrosis (IPF) patients and caregivers who are committed to share...
The Board of Directors of VirtualScopics, Inc. (NASDAQ: VSCP), a leading provider of clinical trial imaging solutions, announced today that Eric T. Converse, 48, has been named president and chief executive officer,...
The Board of Directors of VirtualScopics, Inc. (NASDAQ: VSCP), a leading provider of clinical trial imaging solutions, announced today that Eric T. Converse, 48, has been named president and chief executive officer,...
Boehringer Ingelheim (BI) wants to set the record straight following misleading statements that the British Medical Journal (BMJ) published today regarding Pradaxa® (dabigatran etexilate mesylate). We are concerned that...
Boehringer Ingelheim (BI) wants to set the record straight following misleading statements that the British Medical Journal (BMJ) published today regarding Pradaxa® (dabigatran etexilate mesylate). We are concerned that...
AuraSense Therapeutics, the pioneer in developing spherical nucleic acid (SNA™) constructs as gene regulatory and immunotherapeutic agents, announced today that David Snyder has joined AuraSense Therapeutics' executive...
AuraSense Therapeutics, the pioneer in developing spherical nucleic acid (SNA™) constructs as gene regulatory and immunotherapeutic agents, announced today that David Snyder has joined AuraSense Therapeutics' executive...
IPRO has won an historic, five-year award as the Medicare-funded Quality Innovation Network (QIN) contractor for the states of New York and South Carolina and for the District of Columbia. Under a new arrangement that...
IPRO has won an historic, five-year award as the Medicare-funded Quality Innovation Network (QIN) contractor for the states of New York and South Carolina and for the District of Columbia. Under a new arrangement that...
Research and Markets has announced the addition of the "Sensor Market in Consumer Healthcare by Application, Sensor Type & by Geography - Analysis & Forecast to to 2013 - 2020" report to their offering.
Research and Markets has announced the addition of the "Sensor Market in Consumer Healthcare by Application, Sensor Type & by Geography - Analysis & Forecast to to 2013 - 2020" report to their offering.
V. Craig Jordan, Ph.D., one of the world's preeminent breast cancer experts will join The University of Texas MD Anderson Cancer Center this fall. Jordan is considered the "Father of Tamoxifen," the groundbreaking...
V. Craig Jordan, Ph.D., one of the world's preeminent breast cancer experts will join The University of Texas MD Anderson Cancer Center this fall. Jordan is considered the "Father of Tamoxifen," the groundbreaking...
Good Samaritan Hospital and the University of Southern California Keck School of Medicine Departments of Neurosurgery and Neurology have formed a new affiliation. The USC Neuroscience Center at Good Samaritan Hospital...
Good Samaritan Hospital and the University of Southern California Keck School of Medicine Departments of Neurosurgery and Neurology have formed a new affiliation. The USC Neuroscience Center at Good Samaritan Hospital...
Research and Markets has announced the addition of the "Diagnostic Electrocardiograph (ECG) Market by Product, End-user & by Lead Type - Global Forecast to 2020" report to their offering.
Research and Markets has announced the addition of the "Diagnostic Electrocardiograph (ECG) Market by Product, End-user & by Lead Type - Global Forecast to 2020" report to their offering.
Pharmavite LLC announced that Timothy "Tim" Toll has been named the company's chief customer officer effective immediately. Toll recently served as Pharmavite's executive vice president of sales, overseeing...
Pharmavite LLC announced that Timothy "Tim" Toll has been named the company's chief customer officer effective immediately. Toll recently served as Pharmavite's executive vice president of sales, overseeing...
All content © Copyright 2000-2011 WorldNow and KFDA. All Rights Reserved. For more information on this site, please read our Privacy Policy and Terms of Service.
